| Strain and strain background (Staphylococcus aureus) |
HG003; MSSA |
doi:10.1128/IAI.00088-10
|
BC1561 |
|
| Strain and strain background (S. aureus) |
LAC; CA-MRSA |
doi:10.1073/pnas.0710217105
|
BC1684 |
|
| Strain and strain background (S. aureus) |
JE2 wild-type |
doi:10.1128/mBio.00537-12. |
BC9 |
|
| Strain and strain background (S. aureus) |
JE2 floA::Tn |
doi:10.1128/mBio.00537-12. |
BC1758 |
SAUSA300_1533; From NTML, strain NE184 |
| Strain and strain background (S. aureus) |
JE2 crtM::Tn |
doi:10.1128/mBio.00537-12. |
BC440 |
SAUSA300_2499; From NTML, strain NE1444 |
| Strain and strain background (S. aureus) |
HG003 ezrA-gfp
|
doi:10.1038/nature25506
|
BC1552 |
ezrA-gfp was transduced from ColpSGEzrA-GFP into HG003 background for this work |
| Strain and strain background (S. aureus) |
VISA |
doi:10.1128/AAC.01073-08
|
SA770; BC1477 |
|
| Strain and strain background (S. aureus) |
VRSA |
doi:10.1128/AAC.01073-08
|
VRS2; BC1479 |
Vancomycin-resistant |
| Strain and strain background (Enterococcus faecalis) |
VRE |
doi:10.1128/iai.00425- 15
|
V583; BC231 |
Vancomycin-resistant |
| Strain and strain background (E. faecalis) |
OG1 |
ATCC |
BC524 |
ATCC 47077 |
| Strain and strain background (Enterococcus faecium) |
Clinical isolate |
doi:10.1038/s41564-021-00966-0
|
BC1540 |
|
| Strain and strain background (Bacillus subtilis) |
BS49 |
doi:10.1371/journal.pgen.1006701
|
BC209 |
|
| Strain and strain background (Escherichia coli) |
MG1655 |
ATCC |
BC15 |
ATCC 47076 |
| Strain and strain background (Staphylococcus epidermidis) |
CSF41498 |
doi:10.1128/jb.0194 6-14
|
BC17 |
|
| Chemical compound and drug |
Rhamnolipids |
AGAE Technologies |
Cat#R90 |
|
| Chemical compound and drug |
Palmitoleic acid |
Cayman Chemical |
Cat. #10009871 |
|
| Chemical compound and drug |
Linoleic acid |
Cayman Chemical |
Cat. #90150 |
|
| Chemical compound and drug |
Glycerol monolaurate |
Cayman Chemical |
Cat.#28170 |
|
| Chemical compound and drug |
Lauric acid |
Cayman Chemical |
Cat.#10006626 |
|
| Chemical compound and drug |
Adarotene |
Sigma-Aldrich |
Cat.#SML2061 |
|
| Chemical compound and drug |
Benzyl alcohol |
ThermoFisher |
Cat.#A396500 |
|
| Chemical compound and drug |
Vancomycin |
ThermoFisher |
Cat.#AAJ6279003 |
|
| Chemical compound and drug |
Fosfomycin |
Sigma-Aldrich |
Cat.#P5396 |
|
| Chemical compound and drug |
Oxacillin |
ThermoFisher |
Cat.#AC45544005 |
|
| Chemical compound and drug |
Nafcillin |
ThermoFisher |
Cat.#AC46138001 |
|
| Chemical compound and drug |
Bacitracin |
ThermoFisher |
Cat.#BP29501 |
|
| Chemical compound and drug |
Tarocin A1 |
Sigma-Aldrich |
Cat.#SML1677 |
|
| Chemical compound and drug |
Daptomycin |
MedChem Express |
Cat.#HY-B0108 |
|
| Chemical compound and drug |
zaragozic acid |
Sigma-Aldrich |
Cat.#z2626 |
|
| Chemical compound and drug |
Oritavancin |
Cayman Chemical |
Cat.#24091 |
|
| Chemical compound and drug |
AsKO |
Sigma-Aldrich |
Cat.#A6756 |
|
| Chemical compound and drug |
CCCP |
Cayman Chemical |
Cat.#25458 |
|
| Other |
BODIPY-VAN |
Invitrogen |
Cat.#V34850 |
Fluorescently labeled vancomycin, labeling cell wall, Figure 4
|
| Other |
Nile red |
Sigma-Aldrich |
Cat.#72485 |
Cell membrane dye, Figure 4
|
| Other |
DiI-C12 |
ThermoFisher |
Cat.#D383 |
RIF specific dye, Figure 4
|
| Other |
HADA |
ThermoFisher |
Cat.#66475 |
Dye that stains new cell wall, Figure 7
|
| Other |
WGA-488 |
ThermoFisher |
Cat.#W11261
|
Dye that stains mature cell wall, Figure 7
|
| Other |
Sytox green |
ThermoFisher |
Cat.#S7020 |
Cell viability dye, Figure 5
|
| Commercial assay or kit |
BacTiter-Glo Microbial Viability Kit |
Promega |
Cat.#G8232 |
|
| Software and algorithm |
Graphpad Prism |
Graphpad.com
|
Prism 9 |
|
| Software and algorithm |
Biorender |
Biorender.com
|
|
|
| Software and algorithm |
Metamorph 7.10 |
Molecular Devices |
|
Acquisition software |
| Software and algorithm |
Autoquant |
Media cybernetics |
Version 3.1.3 |
Deconvolution software |
| Software and algorithm |
FIJI |
ImageJ |
v1.53q |
|
